Admin TOA

Admin TOA

Amgen to Acquire Mustafa Nevzat to Tap Growth in Turkey

Image By Marthe Fourcade - Amgen Inc. (AMGN), the world’s largest biotechnology company, agreed to buy closely held Mustafa Nevzat Pharmaceuticals for almost $700 million to expand in Turkey, where economic growth is boosting demand for medicines. Amgen will pay cash to get 95.6 percent of Mustafa Nevzat, or MN Pharmaceuticals as the Istanbul-based generic-drug maker is known, the companies said in a joint statement. The transaction will boost Amgen’s presence in a region that has “large, fast-growing, priority markets,” they said.
  • Published in Latest

Businessman with Ottoman Roots Plans Investment in Turkey

Image Following the world's richest businessman Carlos Slim, another Ottoman descendent is planning to come to Turkey. Brazilian millionaire Joseph Safra, whose ancestors used to trade in Istanbul, has supposedly now set his sights on Turkey. Turkey, which has fast become a highly desirable destination for both European and Asian investors, has now piqued the interest of Latin Americans. After Carlos Slim, the world's richest businessman with a fortune worth 69 billion dollars, another Lebanese-rooted Ottoman descendent is seeking out investments in Turkey.
  • Published in Latest

Turkoglu Fitted for Protective Mask

Image Magic SF Hedo Turkoglu on Tuesday was fitted for a protective mask he will wear if he can return to play in the postseason. Turkoglu underwent surgery to repair fractures to his right cheekbone April 7. The Magic are hoping to have him back in time for the playoffs, which could start for the club either Saturday or Sunday. He did not take part in the contact portion of practice, but shot baskets and worked on some moves with an assistant coach after the Magic's workout on Tuesday.
  • Published in Latest

Senator Teams with Dr. Oz to Crack Down on Designer Drugs

Image Sen. Jeff Klein, D-Bronx, yesterday announced with talk-show host Dr. Mehmet Oz, a cardiothoracic surgeon, that he is sponsoring legislation to ban designer drugs that have been formulated to mimic the effects of Ecstasy, LSD, Ketamine and other controlled substances. They are not regulated under current law and are readily available online.
  • Published in Latest
Subscribe to this RSS feed